Jo S, Lee S, Kim H, Won H, et al. Effectiveness of the 2023-2024 monovalent XBB.1.5 vaccine against SARS-CoV-2 infection in people aged over 65 years in South Korea: A population-based cohort study. Int J Infect Dis 2025 Nov 19:108238. doi: 10.1016/j.ijid.2025.108238.
PMID: 41271028